Panel Debate: Blood-Based Biomarker Tests or Proven CT Scans: Reaching Communities in Need of Lung Cancer Screening
This debate examines whether blood-based biomarker tests or proven low-dose CT scans can better reach underserved communities. Experts weigh accuracy, access, and impact to determine the best path to expand screening and improve early detection.